US Health Spending Doubles Peers as System Fails to Negotiate Prices

vlogbrothers

The US outspends other developed nations on healthcare not because citizens consume more care, but because a fragmented system lacks the collective bargaining power to stop providers from charging inflated rates on inelastic services.

AI-assisted summary of Why Are American Health Care Costs So High? — original source. Check the original for full context.

Source published: 2013-08-20

Key ideas

The United States spends more tax revenue per capita on healthcare than Canada, the UK, Germany, or Australia, yet only about 28% of Americans receive government-funded coverage. (0:00)
High American healthcare spending is driven by exorbitant per-unit prices rather than overutilization, as Americans visit doctors less frequently and spend less time hospitalized than Europeans. (2:08)
Inpatient and outpatient hospital care forms the single largest driver of excess spending at $500 billion per year above baseline expectations, dwarfing drug prices ($100B), administrative overhead ($90B), and defensive medicine ($55B). (3:36)
Unlike centralized foreign systems like the UK's NHS that negotiate bulk purchase contracts, the fragmented US healthcare market faces totally inelastic consumer demand, enabling providers to charge whatever the market will bear. (5:11)

Detailed notes

## Background Published by John Green on the vlogbrothers YouTube channel on August 20, 2013, this video explores the multifaceted reasons why American healthcare expenditures far outstrip those of any other nation. According to the show notes, it serves as the first entry in an educational series leading into the 2014 rollout of the Affordable Care Act, challenging simplistic blame games directed at doctors, lawyers, or insurance companies.

## TL;DR John Green demonstrates that American healthcare is uniquely expensive not because citizens utilize care more or live unhealthier lifestyles, but simply because individual goods and procedures cost significantly more. Despite Americans paying more tax dollars per capita toward healthcare than citizens in the UK, Canada, or Australia, most receive no government coverage, while the nation spends an excess $500 billion per year on inpatient and outpatient hospital care alone. Because healthcare features highly inelastic demand and the fragmented US market lacks centralized purchasing power like Britain's NHS to negotiate rates, providers and suppliers are able to charge whatever the market will bear.

## Atmosphere & style Delivered in signature vlogbrothers fashion, John speaks directly to his brother Hank at a breathless, rapid-fire pace that balances intellectual rigor with exasperated, comic disbelief. The video feels energetic and slightly dizzying, cutting through dense macroeconomic datasets and stark price comparisons with witty banter and self-referential jokes about channel time limits. The underlying tone shifts from engaging myth-busting to genuine, pragmatic urgency as John strips away partisan talking points to expose a complex systemic crisis.

## Bulletin - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) The United States spends more tax revenue per capita on healthcare than Canada, the UK, Germany, or Australia, yet only about 28% of Americans receive government-funded coverage. - [02:08](https://www.youtube.com/watch?v=qSjGouBmo0M&t=128s) High American healthcare spending is driven by exorbitant per-unit prices rather than overutilization, as Americans visit doctors less frequently and spend less time hospitalized than Europeans. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Inpatient and outpatient hospital care forms the single largest driver of excess spending at $500 billion per year above baseline expectations, dwarfing drug prices ($100B), administrative overhead ($90B), and defensive medicine ($55B). - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) Unlike centralized foreign systems like the UK's NHS that negotiate bulk purchase contracts, the fragmented US healthcare market faces totally inelastic consumer demand, enabling providers to charge whatever the market will bear.

## Key takeaways - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) US taxpayers pay more per capita for public healthcare than citizens in nations with universal systems, yet most Americans receive zero public medical benefits. - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) The US consumes roughly 18% of its GDP on healthcare—double Australia's 9%—without seeing superior clinical outcomes, ranking 33rd internationally in life expectancy. - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) Unit costs for medical goods and procedures are drastically higher in the US, such as hip replacements costing over $100,000 compared to $13,000 in Belgium. - [02:08](https://www.youtube.com/watch?v=qSjGouBmo0M&t=128s) Patient overutilization does not account for high costs, as Americans use hospital beds and outpatient consultations less often than Western Europeans. - [02:08](https://www.youtube.com/watch?v=qSjGouBmo0M&t=128s) Lifestyle factors like higher US obesity rates are largely counterbalanced by lower rates of smoking and alcohol consumption compared to countries like France and the UK. - [02:08](https://www.youtube.com/watch?v=qSjGouBmo0M&t=128s) Lack of insurance pushes patients toward emergency rooms for uncompensated care, triggering medical bankruptcies and administrative billing costs subsidized by the insured. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Defensive medicine and malpractice concerns account for $55 billion in excess spending, but represent only about 2% of total US healthcare outlays. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Tort reform provides negligible overall relief, with aggressive lawsuit caps in Texas reducing total healthcare costs by only 0.1%. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Physician and nurse compensation in the US accounts for approximately $75 billion in excess annual costs relative to expectations for a wealthy nation. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Administrative overhead, insurance negotiations, and marketing add roughly $90 billion in excess costs above comparable international benchmarks. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Prescription pharmaceuticals add an extra $100 billion above expectations, caused by high prices per pill rather than higher consumption rates. - [03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Inpatient and outpatient hospital care represents a $500 billion annual excess, standing as the dominant driver of runaway US healthcare spending. - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) Single-payer national systems maintain low costs by leveraging monopsony purchasing power to force suppliers and medical device manufacturers into price competition. - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) Medicare is the sole major domestic payer with sufficient bargaining scale to consistently demand the lowest medical reimbursement rates in the US. - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) Because medical demand is strictly inelastic when survival is at stake, patients lack the leverage to walk away from inflated prices. - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) Attributing healthcare costs to a single scapegoat is inaccurate, as systemic reform requires tackling provider rates, administrative waste, drug pricing, and fragmented bargaining in tandem.

## Detailed walkthrough ### [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) The Per Capita Tax Paradox and the True Cost of Care

John Green opens by preparing to shatter common assumptions about how public and private money flows into healthcare across developed nations. While many Americans believe that citizens in countries like Canada, the United Kingdom, and Australia pay steep tax rates solely to fund a collective public healthcare pot that delivers “free” service, the raw figures tell an astonishingly inverted story. In reality, the United States spends more tax revenue per capita on healthcare than Germany, Australia, the UK, or Canada. Yet despite paying more public tax dollars toward healthcare than an average British citizen, the typical American receives zero government-provided coverage in return. In the US, only about 28% of the population receives coverage through taxpayer-funded programs—primarily limited to the elderly, the poor, and members of Congress—while the overwhelming majority rely on private employer-sponsored plans, driving private spending off the charts.

Overall, the United States consumes roughly 18% of its gross domestic product (GDP) on healthcare, compared to just 9% in Australia. Commentators frequently claim that excessive malpractice lawsuits, widespread obesity, or rampant overmedication explain this disparity, but John cuts straight to the root reality: healthcare in America is expensive simply because every individual good and procedure costs significantly more. Wealthier nations naturally spend slightly more on care, but America spends a staggering amount more without obtaining better health outcomes, leaving the nation effectively paying people to dig holes only to fill them right back up. Life expectancy in the US ranks 33rd internationally, and clinical outcomes for conditions ranging from asthma to cancer remain decidedly ordinary.

“That's right Hank: you pay more in taxes for healthcare than you would if you were British, and in exchange for those taxes, you get no healthcare.”

- Hip replacement: costs $13,000 in Belgium versus upwards of $100,000 in the United States. - Colonoscopy: averages $655 in Switzerland versus more than $1,100 in the US. - Lipitor (one-month supply): costs $7 in New Zealand versus an average of $124 in the US. - US healthcare outcomes across major illnesses, according to nonpartisan research, are “not notably superior.”

[02:08](https://www.youtube.com/watch?v=qSjGouBmo0M&t=128s) Debunking Common Myths: Utilization, Lifestyle, and Systemic Inefficiencies

Turning to widespread theories, John systematically knocks down popular scapegoats, starting with the accusation of “overutilization.” Many commentators argue that Americans drive up spending because they visit physicians too often, demand too many diagnostics, and occupy hospital beds unnecessarily. In truth, Americans consult doctors far less frequently than Europeans and spend considerably less time hospitalized. While John quips that this reluctance makes sense when seven nights in a Dutch hospital cost the same as a single night in an American facility, the data clearly proves that overutilization is not the culprit. Lifestyle choices are likewise unfairly blamed; although the US has higher obesity rates, Americans smoke less and consume less alcohol than populations in the UK or France, balancing out the aggregate lifestyle burden.

The healthcare system also suffers from massive, compounding structural inefficiencies that are notoriously difficult to quantify. When individuals lack health insurance, they still receive medical treatment when acute emergencies strike, but the resulting bills often trigger personal bankruptcy. That failure cascades through the entire economic ecosystem: insured Americans end up subsidizing not only the cost of the unpaid care itself, but also the extensive billing and collection efforts hospitals mount trying to extract payments from destitute patients. Compounding the absurdity, uninsured individuals are routinely locked out of preventative medicine and forced into emergency rooms—the single most expensive setting for treatment.

“Everyone likes to blame obesity on our rising healthcare costs, but yeah, no.”

- Dutch vs. American hospitalization: a patient can stay seven nights in a Dutch hospital for the price of one night in an American hospital. - Disease prevalence and lifestyle factors: higher US obesity is largely offset by lower rates of smoking and alcohol consumption compared to Western Europe. - Uninsured care dynamics: uninsured patients are pushed into high-cost emergency rooms, generating hospital collection overhead and medical bankruptcies that shift financial burdens onto the broader public.

[03:36](https://www.youtube.com/watch?v=qSjGouBmo0M&t=216s) Breaking Down the Numbers: Defensive Medicine, Wages, and the $500 Billion Monster

To determine why American healthcare spending deviates so radically from what an affluent economy should expect to pay, John analyzes quantifiable categories of excess expenditure above baseline expectations. First is malpractice and defensive medicine—the practice of physicians ordering extra MRI and CT scans to protect themselves from legal liability. While defensive testing accounts for an estimated $55 billion in excess spending, it makes up only about 2% of total national healthcare expenditures; furthermore, states like Texas that instituted aggressive tort reform saw their overall healthcare costs decrease by a negligible average of 0.1%. Higher salaries for American doctors and nurses account for roughly $75 billion above expectations. Meanwhile, administrative overhead—encompassing billing paperwork, marketing, and private insurance negotiation—adds an extra $90 billion beyond normal levels, and prescription pharmaceuticals add another $100 billion, driven not by taking more pills, but by exorbitant prices per pill.

The dominant driver of excess costs dwarfs all other categories combined: inpatient and outpatient hospital care. Because American healthcare frequently conducts procedures as outpatient visits (such as gallbladder surgeries) that foreign systems manage as inpatient admissions, John bundles them together into one enormous category. This single sector represents an astonishing $500 billion per year in spending beyond what the size of the American economy would predict.

```mermaid flowchart TD accTitle: Excess Annual US Healthcare Spending Above Wealth Expectations accDescr: A breakdown of excess US healthcare expenditures above expected levels for a wealthy economy, showing small to moderate factors leading up to the dominant inpatient and outpatient sector.

subgraph Secondary["Smaller Contributing Factors (~$320B Total)"] A["Malpractice & Defensive Medicine +$55 Billion (2% of total costs)"] B["Physician & Nurse Compensation +$75 Billion"] C["Administration & Insurance Overhead +$90 Billion"] D["Prescription Drug Pricing +$100 Billion"] end

subgraph Primary["The Dominant Cost Driver"] E["Inpatient & Outpatient Hospital Care +$500 Billion per year"] end

Secondary -.->|"Cumulative impact"| Primary ```

“The biggest estimates for the total costs of defensive medicine put it at around 55 billion dollars, which is a lot of money, but only 2% of our total healthcare costs.”

- Malpractice tort reform impact: limiting lawsuits in states like Texas reduced healthcare costs by only 0.1%. - Defensive medicine total: approximately $55 billion per year. - Healthcare professional salaries: approximately $75 billion per year above wealth expectations. - Administrative, marketing, and paperwork costs: approximately $90 billion per year above wealth expectations. - Prescription drug prices: approximately $100 billion per year above wealth expectations. - Inpatient and outpatient hospital care: $500 billion per year above wealth expectations.

[05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) Inelastic Demand and the Failure of Price Negotiation

The reason inpatient and outpatient care generates a $500 billion annual excess is the total absence of aggressive, centralized price negotiation. In countries like the UK, the National Health Service uses its massive purchasing power to negotiate contracts on behalf of the entire population. When sourcing medical equipment like artificial hips, the government tells manufacturers that a massive contract covering England, Scotland, Wales, and Northern Ireland will go strictly to whichever vendor offers proven safety at the lowest price, forcing suppliers into fierce price competition. In contrast, the United States market is decentralized and fragmented, preventing private payers from exerting meaningful leverage. The sole major domestic exception is Medicare, which covers the elderly and consistently secures the lowest reimbursement rates in the country.

This lack of institutional bargaining runs headlong into the economic reality of healthcare: inelastic demand. When consumers purchase everyday consumer items like a MacBook Air or wait for the next season of *Sherlock*, demand is elastic and based on choice. But medical care involves literal physical survival. If a pharmaceutical manufacturer charges $7 a month for a life-saving medication, a patient pays $7; if the manufacturer raises the price to $124 a month, the patient has no choice but to scrape together $124. Individual patients cannot bargain effectively because they cannot simply walk away from life-preserving care, allowing providers and suppliers to charge whatever the market will bear.

John stresses that public discourse continually errs by reducing this crisis to single-cause finger-pointing—blaming only trial lawyers, greedy doctors, insurance executives, drug manufacturers, or government regulators. In reality, all of these elements intertwine to create the single largest drag on the US economy. Wrapping up with a self-referential nod to vlogbrothers rules, John reminds viewers that educational videos are permitted to exceed four minutes, playfully chiding commenters who complained about time limits before feeling dizzy from the rapid-fire breakdown.

“So basically, Hank, in the United States, providers charge whatever they think they can get away with, and they can get away with a lot, because it's really difficult to put a price on, like, not dying.”

- Monopsony leverage abroad: centralized buyers like the NHS pit medical device and drug suppliers against each other to guarantee lowest-possible pricing. - Inelastic demand reality: patients cannot bargain or refuse care when faced with life-or-death medical needs. - Systemic consensus: sustainable reform requires addressing malpractice, provider incentives, insurer overhead, drug patents, and fragmented bargaining simultaneously rather than treating the issue as political theater.

## Notable quotes > [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) In the United States, providers charge whatever they think they can get away with, and they can get away with a lot, because it's really difficult to put a price on, like, not dying. — John Green

## Mentioned John Green, Hank Green, Affordable Care Act, Obamacare, The Incidental Economist, The Commonwealth Fund, The New York Times, Lipitor, Medicare, National Health Service, MacBook Air, Sherlock

## Video description In which John discusses the complicated reasons why the United States spends so much more on health care than any other country in the world, and along the way reveals some surprising information, including that Americans spend more of their tax dollars on public health care than people in Canada, the UK, or Australia. Who's at fault? Insurance companies? Drug companies? Malpractice lawyers? Hospitals? Or is it more complicated than a simple blame game? (Hint: It's that one.)

For a much more thorough examination of health care expenses in America, I recommend this series at The Incidental Economist: http://theincidentaleconomist.com/wordpress/what-makes-the-us-health-care-system-so-expensive-introduction/ The Commonwealth Fund's Study of Health Care Prices in the US: http://www.commonwealthfund.org/~/media/Files/Publications/Issue%20Brief/2012/May/1595_Squires_explaining_high_hlt_care_spending_intl_brief.pdf Some of the stats in this video also come from this New York Times story: http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html?pagewanted=all

This is the first part in what will be a periodic series on health care costs and reforms leading up to the introduction of the Affordable Care Act, aka Obamacare, in 2014.

[Source](https://www.youtube.com/watch?v=qSjGouBmo0M)

中文简报

缺乏议价能力致美国医疗支出达同类国家两倍美国在医疗保健方面的支出超过其他发达国家，并非因为其国民消耗了更多医疗服务，而是因为高度分散的体系缺乏集体议价能力，无法阻止医疗机构对缺乏需求弹性的服务收取虚高费用。约翰·格林指出，美国医疗费用的奇高并非源于国民使用了更多医疗服务或生活方式更不健康，而纯粹是因为各项医疗物资和操作流程的单价要高得多。尽管美国人均缴纳的医疗税负高于英国、加拿大或澳大利亚的公民，但大多数美国人并未享受政府提供的医疗保障；与此同时，仅住院和门诊医疗护理一项，美国每年就多支出5000亿美元。由于医疗服务具有高度缺乏需求弹性的特点，加之美国分散的市场缺乏像英国国家医疗服务体系（NHS）那样的集中采购力来协商价格，医疗机构和供应商便能够按市场所能承受的最高限度随意定价。美国人均用于医疗的税收支出超过加拿大、英国、德国或澳大利亚，但仅有约28%的美国人享有政府资助的医疗保障。 (0:00) 美国高昂的医疗支出是由过高的单项价格驱动的，而非过度使用服务所致；实际上，美国人看医生的频率和住院时间均低于欧洲人。 (2:08) 住院和门诊医疗护理是导致超额支出的最大单一驱动因素，每年超出基准预期5000亿美元，使药品价格（1000亿美元）、行政管理开销（900亿美元）和防御性医疗（550亿美元）相形见绌。 (3:36) 不同于能够通过大宗采购合同进行价格谈判的英国NHS等集中化外国体系，美国分散的医疗市场面临着完全缺乏弹性的消费需求，使得医疗机构得以按市场所能承受的最高限度任意要价。 (5:11)

Reading summary

John Green argues that American healthcare costs are exceptionally high not because of excessive utilization or uniquely unhealthy lifestyles, but because every good, service, and procedure is priced significantly higher than in other developed nations. The Paradox of High Taxes and Mediocre Outcomes (0:00) Despite widespread assumptions that single-payer systems require heavier taxation, the United States spends more public tax revenue per capita on healthcare than Germany, Australia, the United Kingdom, or Canada. Yet while roughly 18% of US gross domestic product goes toward healthcare compared to 9% in Australia, only about 28% of Americans receive taxpayer-funded coverage—primarily limited to the poor, the elderly, and members of Congress. The vast majority of citizens must still rely on private employer-sponsored plans. Dismantling Utilization and Lifestyle Myths (2:08) Higher costs are frequently blamed on overutilization or lifestyle choices, but data contradicts both claims. Americans consult doctors less frequently and spend fewer nights in the hospital than their European counterparts, with one night in an American hospital matching the cost of seven nights in a Dutch facility. While the US exhibits higher obesity rates, this factor is broadly balanced out by lower smoking and alcohol consumption rates relative to countries like France and the UK. Instead, severe structural inefficiencies inflate the system. Because uninsured individuals lack access to preventative care, they rely heavily on high-cost emergency rooms during acute crises. The resulting medical bankruptcies leave insured populations subsidizing both the uncompensated care and the administrative expenses hospitals incur while pursuing collections. Quantifying the Excess: Hospital Care as the Dominant Driver (3:36) Examining expenditures above what a wealthy economy should predict shows that defensive medicine and malpractice contribute roughly $55 billion per year, representing only about 2% of overall healthcare spending; tort reform in Texas reduced total costs by a negligible 0.1%. Higher clinician compensation adds about $75 billion, administrative and insurance overhead adds $90 billion, and prescription drug pricing accounts for $100 billion. The single largest cost driver, however, is inpatient and outpatient hospital care, which accounts for $500 billion annually beyond wealth-adjusted baselines. For individual treatments, disparities are stark: a hip replacement costs $13,000 in Belgium versus upwards of $100,000 in the US, while a one-month supply of Lipitor costs $7 in New Zealand compared to $124 in the US, despite nonpartisan research showing US outcomes for conditions like cancer and asthma are not notably superior. Fragmented Markets and Inelastic Demand (5:11) The massive excess in hospital and procedural spending stems from a lack of centralized bargaining power coupled with perfectly inelastic demand. In foreign single-payer systems such as the UK National Health Service, a central buyer exercises monopsony power by conditioning large national contracts on competitive pricing. In contrast, the fragmented US market leaves private insurers with limited leverage, with Medicare remaining the sole domestic exception securing systematically lower reimbursement rates. Because healthcare involves literal survival, consumers lack normal market elasticity and cannot walk away when prices rise. Without collective negotiation to restrain charges, providers and medical suppliers are able to bill whatever the market can bear. The analysis concludes that American healthcare spending cannot be solved by singling out isolated scapegoats—such as malpractice attorneys, drug manufacturers, or insurers. Because these mechanisms are mutually reinforcing and act as the single largest drag on the US economy, sustainable reform requires addressing provider incentives, insurance administration, drug pricing, and fragmented bargaining in tandem.

精炼阅读摘要

John Green指出，美国医疗支出居高不下的根源并非过度就医、生活方式或诉讼泛滥，而在于医疗商品与服务单价普遍昂贵。在缺乏集中议价权和医疗需求刚性的共同作用下，住院与门诊服务构成了高达5000亿美元的超额支出核心。财政人均悖论与脱节的医疗产出 (0:00) 许多人误以为全民公费医疗国家的公民承担了极高的税率，而美国通过私人市场控制了公共税收负担。但数据显示，美国人均用于医疗的税收支出实际上高于德国、澳大利亚、英国或加拿大。荒谬之处在于，尽管美国普通民众在医疗上承担了高于英国人的公共税款，却无法像后者那样获得政府提供的基础医疗保障；全美仅有约28%的人口（主要是老年人、低收入群体和国会议员）受公共项目保障，绝大多数居民仍依赖私人雇主医保，导致私人支出呈爆发式增长。从宏观来看，美国医疗支出约占国内生产总值（GDP）的18%，远超澳大利亚的9%。然而，巨额的资金投入并没有换来相应的健康回报。美国的人均预期寿命在全球仅排在第33位，非党派机构的研究表明，其针对哮喘、癌症等重大疾病的临床成效并不显著优于其他国家。具体开销差异极为惊人：在比利时仅需13000美元的髋关节置换术，在美国高达100000美元以上；瑞士平均655美元的结肠镜检查，在美国超过1100美元；一瓶一个月用量的立普妥（Lipitor），新西兰仅售7美元，而在美国平均售价高达124美元。这种高额花费如同雇人挖坑再填坑，未能带来附加的健康红利。破除过度就医与生活方式归因神话 (2:08) 舆论常将高昂的医疗开支归咎于美国人的生活习惯或“过度使用”医疗资源，但客观数据驳斥了这些说法。与欧洲人相比，美国人看医生的频率更低，住院时间也明显更短。例如，在荷兰住院七晚的费用仅相当于在美国住院一晚。在生活方式方面，虽然美国的肥胖率较高，但美国人的吸烟率和饮酒量均低于英法等西欧国家，群体层面的健康风险在很大程度上得到了相互抵消，因而生活方式绝非主因。更为隐蔽且严重的成本来自制度性低效。缺乏医疗保险的群体在遭遇突发急症时仍会被收治，但巨额账单往往导致个人破产。这种坏账连锁反应波及整个经济系统：有保险的投保人不仅需要分摊这些未偿还的医疗坏账，还得承担医院雇佣催收机构所耗费的大量行政开销。雪上加霜的是，无保人群因无法获取预防性医疗服务，往往被迫直接进入收费最昂贵的急诊室，从而进一步推高了全社会的隐性医疗负担。超额医疗支出的构成与住院门诊重担 (3:36) 若以同等富裕经济体的标准衡量，美国医疗体系存在大量脱离基准的“超额开支”。针对行业普遍诟病的医疗差错诉讼与防御性医疗（即医生为防范法律责任而过度开具MRI或CT检查），其产生的超额开支约为550亿美元，仅占全美医疗总支出的2%左右；得克萨斯州实施的严格侵权法改革最终也仅使医疗费用微弱下降了0.1%，证明法律诉讼并非关键杠杆。此外，美国医生和护士的高薪资水平贡献了约750亿美元的超额支出，涵盖账单处理、营销和保险谈判的行政管理成本带来了约900亿美元超额支出，而高昂的处方药单价又增加了1000亿美元。然而，与住院和门诊医疗服务相比，上述因素的影响都相形见绌。由于美国医疗体系频繁将原本可在门诊完成的手术转为高规格流程，或将胆囊切除等手术归类处理，John Green将住院与门诊合并统计。该领域每年产生的超额支出高达惊人的5000亿美元，成为碾压其他所有细分领域的单一最大成本驱动因素。集中议价机制缺位与刚性需求困境 (5:11) 导致住院和门诊护理年增5000亿美元超额开支的深层经济机制，在于集中采购与激进价格谈判的制度性缺失。以英国国民医疗服务体系（NHS）为例，国家买家凭借庞大的单一市场规模统一招标，要求供应商在保障安全的前提下进行底线价格竞争，从而牢牢压低了人工关节等设备耗材的成本。相比之下，美国医疗市场高度碎片化，私人保险机构缺乏强有力的议价筹码，全美仅有覆盖老年人的联邦医疗保险（Medicare）能行使部分集中议价权并获得国内最低的报销费率。这种议价机制的溃败直接撞上了医疗消费的“需求完全无弹性”。与普通电子消费品或娱乐产品不同，医疗服务直接关乎患者的生命存续。当救命药物的价格由每月7美元暴涨至124美元时，患者由于无法选择放弃生命，只能被迫承受任何溢价。医疗服务提供方因此得以按照市场所能容忍的最高极限随意定价，导致价格机制彻底脱离成本约束。 John Green强调，美国医疗危机是系统性相互交织的结果，不能简单归咎于律师、医生、药企、保险公司或监管机构中的任何单一群体。若要从根本上遏制这一拖累美国经济的最大包袱，政策制定者必须放弃单一推责的政治作秀，在防御性医疗、专业薪酬激励、行政开销、药品专利保护以及分散的买方议价权等多个维度展开同步改革。

Detailed notes — zh

## Background 该视频由频道 vlogbrothers 于 2013 年 8 月 20 日发布在 YouTube 平台上。视频简介指出，John Green 在本期节目中深入探讨了美国医疗开支远超世界其他各国的复杂成因，揭示了美国人在公立医疗上缴税额反超英加澳的惊人事实，并强调高昂医疗成本并非单一责任方所致，而是多重体制机制交织的结果。 ## TL;DR John Green 首先破除了“过度就诊”和“体质过差”等流行迷思，指出美国医疗昂贵的最根本原因在于各项服务和药品的单价本身极其昂贵，且巨额花销并没有换来更高的预期寿命或更好的医疗成果。通过逐项拆解防卫性医疗、薪酬溢价、行政费用和药价，他揭示出最大的开支黑洞在于每年超出合理预期 5,000 亿美元的住院与门诊诊疗。核心症结在于美国医疗体系极度碎片化，缺乏像英国国家医疗服务体系（NHS）那样代表全体患者的集中议价权，加之医疗属于关乎生死的“非弹性需求”，促使服务机构能随意最大化定价。最终他呼吁公众放弃寻找单一替罪羊的简单化思维，严肃正视这一严重拖累美国经济的复杂体制困局。 ## Atmosphere & style 整段视频延续了 vlogbrothers 极具辨识度的连珠炮式快节奏独白，语速飞快且信息密度极高。John Green 带着一种兼具黑色幽默、愤慨与深切焦虑的知识分子气质，直截了当地用冷酷数据刺破各种常见的政治口号与舆论偏见。观众在观看时既能感受到他面对体制荒诞时的苦笑与犀利吐槽，也能体会到他对于普通病患被沉重医疗账单裹挟的真诚关切，整体观感紧凑深刻、发人深省而又极具紧迫感。 ## Bulletin - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) 美国人均在医疗上缴纳的公共税款超过英国、加拿大和澳大利亚，但仅约28%的人口享有政府资助的医保，整体医疗总开支占GDP高达18%。 - [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 在剔除经济体量差距后的各项超额支出中，住院与门诊服务单项超额达5000亿美元，是美国医疗体系中最大的成本黑洞。 - [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 防卫性医疗（因担心诉讼而开具额外检查）常被舆论抨击，但其占总医疗开支仅约2%，侵权法改革平均仅能压降0.1%的医疗成本。 - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) 缺乏集中统一定价与国家级议价权，加之医疗属于无弹性的刚性生理需求，是导致美国药品与核心诊疗服务单价居高不下的根本机制诱因。 ## Key takeaways - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) 美国存在显著的医疗税收悖论：公民人均缴纳的公立医疗税金高于英国、德国和加拿大，但绝大多数普通人并未因此获得国家医保覆盖。 - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) 美国医疗总开支占GDP的18%（相比之下澳大利亚仅为9%），但高支出并未带来相应优越的健康产出，预期寿命仅位列世界第33位。 - [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) 同类医疗项目与药品在美国的价格远超别国，如立普妥在新西兰单月费用为7美元，而在美国平均高达124美元。 - [02:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=131s) 过度就医不是高成本的原因，美国人看医生和住院的频率均低于欧洲国家。 - [02:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=131s) 不能单纯将高医疗费归咎于肥胖，美国较低的吸烟与饮酒率在宏观健康水平上抵消了肥胖的影响。 - [02:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=131s) 无医保群体因无力支付急诊账单申请破产，其欠费成本和行政催缴开支最终转嫁给了全社会的参保人与就医者。 - [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 防卫性医疗产生约550亿美元超额开支，但即便推行侵权法改革也仅降低了0.1%的医疗成本，影响有限。 - [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 医护薪资溢价（约750亿美元）和繁杂的商业保险行政与营销成本（约900亿美元）也是推高总支出的重要组成部分。 - [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 处方药每年超额支出达1000亿美元，核心症结在于单粒药片价格远高于国际市场，而非人均服药量过多。 - [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 住院与门诊服务构成了每年高达5000亿美元的超额开支，是美国医疗费用居高不下的最大来源。 - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) 缺乏类似英国NHS代表全体国民的集中议价机制，使医疗服务机构能够按照自身利润最大化自由定价。 - [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) 医疗服务具有极低的需求弹性，患者面临生死关头无法有效议价或放弃治疗，导致市场调节机制失灵。 - [06:54](https://www.youtube.com/watch?v=qSjGouBmo0M&t=414s) 高昂医疗成本是由诉讼、行政、药企、医院与议价缺失等多重因素共同造成的系统性顽疾，已成为美国经济面临的最大单项拖累。 ## Detailed walkthrough ### [00:00](https://www.youtube.com/watch?v=qSjGouBmo0M&t=0s) 令人震惊的税收悖论与高昂的医疗开支 John Green 以标志性的快节奏开场，直接向观众抛出一个反常识的真相：人们普遍认为英国、澳大利亚和加拿大等国家能享受所谓的“免费”医疗，纯粹是因为民众缴纳了更高的税收，而政府将税金汇集起来支付国民医疗；然而事实恰恰相反，美国人均在医疗上花费的公立税款，比德国、澳大利亚、英国或加拿大都要高。面对镜头，John 直白地指出这种巨大的落差：“That's right Hank: you pay more in taxes for healthcare than you would if you were British, and in exchange for those taxes, you get no healthcare.”（没错，Hank：你为了医疗所交的税比英国人还要多，但作为交换，你却根本没有享受到医疗保障。）实际上，全美仅有约 28% 的人口通过政府资助的计划获得医保，主要涵盖穷人、老人以及国会议员。对于绝大多数依靠雇主购买商业医保的普通美国人而言，私营医疗开支更是高得惊人。目前美国的医疗总支出约占其国内生产总值（GDP）的 18%，相比之下，澳大利亚的这一比例仅为 9%。面对媒体常常归咎于肥胖、过度用药或医疗诉讼的论调，John 指出问题的核心其实极其直白：单纯是因为“每样东西都更贵”。 - **髋关节置换手术**：在比利时仅需 13,000 美元；在美国通常超过 100,000 美元。 - **结肠镜检查**：在瑞士均价为 655 美元；在美国平均单次超过 1,100 美元。 - **立普妥（Lipitor，降脂药）**：一个月用量在新西兰仅需 7 美元；在美国平均花费却高达 124 美元。美国固然比这些国家更富裕，理应多花一些钱，但实际花销已经远超合理范畴，且巨额花费并没有换来更优越的医疗产出。美国的预期寿命仅排在世界第 33 位；根据一项无党派独立研究，从哮喘到癌症，美国的实际医疗成果并无显著优势，其庞大的支出在本质上就像是在“花钱雇人挖坑，再花钱雇人把坑填上”。 --- ### [02:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=131s) 破除迷思：并非“过度就诊”或“体质较差” 在分析真正原因前，John 首先排除了两个经常被大众和媒体误导的假象： 1. **所谓的“过度使用”（Overutilization）**：许多人以为美国人看病太频繁、检查做得太多、住院时间太长。但统计数据恰恰相反——美国人看医生的频率比欧洲人低，住院天数也少得多。对此 John 打趣道，毕竟在荷兰住 7 晚医院的费用才抵得上在美住院 1 晚，大家不敢住院也是合情合理的。 2. **美国人比别国人更易生病**：舆论普遍习惯将高成本归咎于美国的肥胖率，但数据并不支持这种说法。疾病患病率对宏观医疗成本的影响远没有想象中那么大；更何况，尽管美国的肥胖率较高，但吸烟率和人均饮酒量却显著低于英法等国，彼此抵消之后，整体健康状况大体打成平手。此外，体系本身的低效也带来隐形成本。由于缺乏普遍医疗保障，未参保者一旦生病依然会接受救治，但因无力承担账单常常被迫申请个人破产。这不仅毁了个人的财务状况，其他所有人也不得不承担连带后果——大家不仅要分摊未参保者的实际治疗费，还要承担医院雇人催讨欠款的行政开销。更荒谬的是，许多未参保者生病后没有基层医疗渠道，只能涌向成本最昂贵的急诊室（ER）。 --- ### [03:37](https://www.youtube.com/watch?v=qSjGouBmo0M&t=217s) 成本拆解：美国多花的钱到底去了哪里？撇开经济富裕带来的自然上浮，美国在各环节的“超额开支”（超出经济体量预期外的支出）极其惊人。John 将具体细项层层拆解，展示了各项多花支出的具体规模： ```mermaid flowchart LR accTitle: 超出经济体量预期的美国年度医疗额外开支构成 accDescr: 横向流程图，自左向右展示防卫性医疗、医护薪酬、行政管理、药品加价，以及最大的住院与门诊服务额外支出。 subgraph Defense["诉讼与薪酬"] A["防卫性医疗 ~$550亿"] B["医护人员薪酬 ~$750亿"] end subgraph Admin_Meds["管理与药品"] C["保险与行政成本 ~$900亿"] D["处方药单价溢价 ~$1000亿"] end subgraph Core["核心诊疗服务"] E["住院与门诊服务 ~$5000亿/年"] end Defense --> Admin_Meds Admin_Meds --> Core ``` - **防卫性医疗（Defensive Medicine）**：医生出于对巨额医疗事故诉讼的恐惧，会开具大量非必要的检查以求自保（这导致美国的 MRI 和 CT 扫描量高居全球之首）。但即便在得克萨斯等推行了侵权法改革（Tort reform）以限制医疗诉讼赔偿的州，医疗成本平均也仅下降了微不足道的 0.1%。全美防卫性医疗的最高估计成本约为 550 亿美元，仅占整体医疗费用的 2%。 - **医护人员薪酬（Doctor and Nurse Pay）**：美国医生和护士的薪资普遍高于国际同行，这部分超额支出估算约为 750 亿美元。 - **保险与行政管理成本（Administration Costs）**：繁重的文书处理、广告营销及多方议价流程，导致行政费用比预期高出约 900 亿美元。 - **处方药品（Prescription Drugs）**：每年超出预期的开销达 1,000 亿美元。这并非因为美国人服用的药丸数量过多，而是因为每粒药的单价远高于国际市场。 - **住院与门诊治疗（Inpatient and Outpatient Care）**：这一项是最大的“无底洞”。由于美国医院常将胆囊切除等别国需要住院的手术转为门诊完成，John 将二者合为一个整体。考虑到美国整体经济规模，美国每年在这项服务上的额外开销竟高达 **5,000 亿美元**。 --- ### [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) 缺乏集中议价权与“非弹性需求”的困境针对每年 5,000 亿美元的诊疗与药品黑洞，John 一针见血地指出了制度根源：**美国缺乏集中的强力价格谈判机制**。在英国等国家，国家医疗服务体系（NHS）会代表全体国民进行单一窗口采购。面对人造髋关节供应商，英国政府有底气提出：“我们拥有整个英格兰、苏格兰、威尔士和北爱尔兰所有需要换关节病患的超级大单；你们的产品必须既安全又便宜，否则合同就归竞争对手。”这种极具分量的采购谈判，迫使厂家大幅降价。而在美国，碎片化的体制彻底瓦解了议价权；唯一的例外是面向老年群体的联邦医疗保险（Medicare），而这恰恰是全美医疗定价最低的领域。在这种失衡的体系下，医疗服务机构完全是按照自身所能争取的最大利益来定价，并且往往屡试不爽。John 引用经济学中的“需求无弹性”（Inelastic demand）解释了患者在生死关头的被动局面：“You can't negotiate effectively on your own behalf for healthcare services because you NEED them.”（你根本无法为了自身的医疗服务展开有效议价，因为你对它有着‘刚性需求’。）如果一种救命药物标价每月 7 美元，患者会支付；若标价每月 124 美元，病患为了活命砸锅卖铁也会凑出这笔钱。这根本不像买台 MacBook Air 笔记本或追一季《神探夏洛克》（Sherlock）那样可以选择放弃，这是关乎生死的生理刚需。因此，只要美国无法像澳大利亚和英国那样代表患者展开强有力的集中议价，医疗支出就必将继续领跑全球，而医疗质量却难以得到实质改善。 --- ### [06:54](https://www.youtube.com/watch?v=qSjGouBmo0M&t=414s) 拒绝单一归咎：复杂的现实与经济沉疴针对公共舆论中流行的简单化论调，John 表达了强烈的厌倦。人们总想抓出一个替罪羊——有人怪罪医疗诉讼律师，有人指责医生经商，有人声讨商业保险公司或严苛的投保门槛，还有人归咎于制药巨头、官僚机构或定价机制的缺位。John 情绪激烈地总结道：“It is all of those things and more! It is not a simple problem, there will not be a simple solution, but it is probably the biggest single drag on the American economy and it's vital that we grapple with it meaningfully instead of just treating healthcare costs as political theatre.”（所有这些原因全都属实，甚至远不止于此！这绝非一个简单的问题，也不存在简单的解法；但这很可能是美国经济目前面临的最大单项拖累，我们必须以严肃的态度去应对它，而不是仅仅把医疗成本当作政治作秀的道具。）在视频的尾声，John 说明了自己在简介（doobly-doo）中附上了严谨中立的研究报告链接供大家拓展阅读，并调侃从海外回国的 Hank：“欢迎回到美国，如你所见，这里一切‘好得很’。”随后他顺便提醒弹幕和评论区的观众：科普教育类视频本来就允许超过四分钟，那些在评论区嚷嚷着自己被超长视频“折磨”的人显然根本没有坚持看到最后，并半开玩笑地叹道自己讲得都有些头晕了。 ## Notable quotes > [05:11](https://www.youtube.com/watch?v=qSjGouBmo0M&t=311s) You can't negotiate effectively on your own behalf for healthcare services because you NEED them. — John Green ## Mentioned John Green, Hank Green, Affordable Care Act, The Incidental Economist, The Commonwealth Fund, The New York Times, 立普妥 (Lipitor), 英国国家医疗服务体系 (NHS), Medicare, MacBook Air, 《神探夏洛克》(Sherlock) ## Video description In which John discusses the complicated reasons why the United States spends so much more on health care than any other country in the world, and along the way reveals some surprising information, including that Americans spend more of their tax dollars on public health care than people in Canada, the UK, or Australia. Who's at fault? Insurance companies? Drug companies? Malpractice lawyers? Hospitals? Or is it more complicated than a simple blame game? (Hint: It's that one.) For a much more thorough examination of health care expenses in America, I recommend this series at The Incidental Economist: http://theincidentaleconomist.com/wordpress/what-makes-the-us-health-care-system-so-expensive-introduction/ The Commonwealth Fund's Study of Health Care Prices in the US: http://www.commonwealthfund.org/~/media/Files/Publications/Issue%20Brief/2012/May/1595_Squires_explaining_high_hlt_care_spending_intl_brief.pdf Some of the stats in this video also come from this New York Times story: http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html?pagewanted=all This is the first part in what will be a periodic series on health care costs and reforms leading up to the introduction of the Affordable Care Act, aka Obamacare, in 2014. [Source](https://www.youtube.com/watch?v=qSjGouBmo0M)

Source quotes

[5:11] John Green: You can't negotiate effectively on your own behalf for healthcare services because you NEED them.

Source quotes

[5:11] John Green: In the United States, providers charge whatever they think they can get away with, and they can get away with a lot, because it's really difficult to put a price on, like, not dying.

Original transcript

[0:00] Good morning Hank, it's Tuesday. I want to talk today about why healthcare costs in the [0:03] United States are so phenomenally, fascinatingly expensive, but first I have to blow your mind: [0:08] Alright, so you've probably heard that the reason that people enjoy "free" healthcare [0:13] in Australia and the UK and Canada, etc, etc is that they pay higher taxes. That money [0:19] then goes into a big pot and is used to pay for people's healthcare, but in fact, in the [0:23] US, we spend more tax money per capita on healthcare than Germany, Australia, the UK, [0:30] or Canada. [0:31] That's right Hank: you pay more in taxes for healthcare than you would if you were British, [0:36] and in exchange for those taxes, you get no healthcare. [0:39] In fact, only about 28% of Americans get their health insurance through government funded [0:44] programs, mostly poor people, old people, and Congresspeople. But as you can see in [0:47] this graph our private healthcare spending (most Americans are privately insured through [0:51] their employers) is WAY higher than anywhere else in the world. [0:55] In total, the US currently spends about 18% of its gross domestic product on healthcare costs. [1:02] Australia by comparison? 9%. [1:03] Why is this? Well because everything costs more, which seems obvious, but apparently [1:08] isn't, because every article you read is like "Oh it's because of malpractice insurance" [1:12] or "it's because we're obese" or we go to the doctor too much or people are prescribed [1:17] too many medications. Well, not really. [1:20] It's because everything costs more. A hip replacement in Belgium costs $13,000. In the [1:25] US it's often over $100,000. Colonoscopies average over $1100 a piece in the US; in Switzerland [1:31] they're $655. And on average a month of the drug Lipitor will cost you $124 if you live [1:37] in the US. If you live in New Zealand? $7. [1:40] Now we are also—not to brag—richer than all of these countries, so it makes sense [1:44] that we should spend a little more on healthcare. But we don't spend a little more. We spend [1:49] a ton more. And vitally, we don't get anything for that money, which means we are essentially [1:54] paying people to dig holes and then fill those holes back up. Like we don't live longer—in [1:59] fact we're 33rd in life expectancy—and in everything from asthma to cancer, according [2:03] to one recent nonpartisan study, American healthcare outcomes are "not notably superior." [2:08] So why are we spending all of this money for nothing? Well first, let's discuss some of [2:11] the problems that are not actually problems. [2:13] For instance, the problem is not so-called "overutilization:" the idea that Americans [2:18] go to the doctor more and get more tests and spend more time in hospitals. We know this [2:22] because Americans actually go to the doctor less than Europeans and spend much less time [2:26] in hospitals, although to be fair, you can stay in a Dutch hospital for seven nights [2:30] for what it costs to stay in an American hospital for one night, so no wonder we're hesitant. [2:34] Also it is not because we're sicker than other people. Everyone likes to blame obesity on [2:39] our rising healthcare costs, but yeah, no. That argument is just not supported by data. [2:43] For one thing, disease prevalence does not affect healthcare costs that much. And for [2:47] another thing, while we do have more obesity in the United States, which sometimes leads [2:50] to health problems, we have fewer smokers and less alcohol consumption (really? Apparently [2:55] yes). So that saves us a little money, and if you compare us to like the British or the [2:59] French, in the end it's probably a wash. [3:01] Hank, the truth, as usual, is complex. Like, there are obvious inefficiencies in our healthcare [3:06] system. For instance, not everyone has insurance. If you don't have insurance, you still get [3:10] healthcare, but you're responsible for paying for that healthcare, which often you can't [3:14] do, so you end up going bankrupt. That sucks for you, obviously, because you're bankrupt, [3:18] but it also sucks for the rest of us because we have to pay not only for your care, but [3:22] also for all the money the hospital spent trying to get you to pay for your care. Also [3:26] the only options available to uninsured people are usually the most expensive options, like [3:31] emergency rooms, which is just BANANAS. But those inefficiencies are hard to measure. Fortunately, [3:36] there are things we can measure. [3:37] So like I said before, because the US is one of the richest countries in the world, you [3:40] would expect us to pay a little more for healthcare than most people. The question is, when do [3:44] we pay MORE than you would expect us to pay, and that turns out to be pretty interesting. [3:48] Let's start with malpractice and so-called "defensive medicine." The idea here is that [3:52] doctors are scared of huge malpractice suits so they order a lot of unnecessary tests [3:57] in order to, like, cover their butts. That does contribute to our healthcare costs, like [4:00] there are more MRI and CT scans in the US than anywhere else. However, there are a bunch [4:04] of states like Texas that have passed tort reform to limit malpractice suits, and in [4:08] those states healthcare costs have dropped by an average of a whopping 0.1%. The biggest [4:14] estimates for the total costs of defensive medicine put it at around 55 billion dollars, which [4:19] is a lot of money, but only 2% of our total healthcare costs. [4:23] Another smallish factor: doctors (and to a lesser extent, nurses) are paid more in the [4:26] US than they are in other countries, and by my possibly-faulty math we end up spending [4:31] about 75 billion dollars more than you would expect us to there. [4:33] And then we have the cost of insurance and administration costs, like paperwork and marketing [4:38] and negotiating prices. That's about 90 billion dollars more than you would expect us to spend. [4:44] We spend about $100 billion more than you would expect on drugs, not so much because [4:47] we take MORE of them, but because the ones we take cost more per pill. [4:51] Okay, and now for the big one. I'm gonna lump inpatient and outpatient care together, because [4:56] in the US we do a lot of things as outpatient procedures, like gallbladder surgeries, that [4:59] are often inpatient procedures in other hospitals. We're just gonna make a big ball [gestures]. [5:04] That big ball is $500 billion more than what you would expect given the size of our economy. [5:10] Per year. [5:11] Why? Because in the United States we do not negotiate as aggressively as other countries do with [5:16] healthcare providers and drug manufacturers and medical device makers. So like in the [5:21] UK the government goes out to all the people who make artificial hips and says "One of [5:24] you is going to get to make a crapton of fake hips for everybody who is covered by the NHS [5:31] here in the United Kingdom. But you better make sure your hips are safe, and you better [5:34] make sure that they are cheap, because otherwise we're going to give our business to a different [5:39] company." And then all the fake hip companies are motivated to offer really low prices because [5:42] it's a really huge contract. Like think if your company got to put hips inside of [5:47] everyone in England and Scotland and Wales and Northern Ireland (I guess not everyone. [5:51] Just the people who need hips). [5:52] But in the US we don't have any of that centralized negotiation, so we don't have as much leverage. [5:58] The only big exception is Medicare, the government-funded healthcare for old people, which, not coincidentally, [6:03] always gets the lowest prices. [6:04] So basically, Hank, in the United States, providers charge whatever they think they [6:08] can get away with, and they can get away with a lot, because it's really difficult to put [6:12] a price on, like, not dying. This is a phenomenon called "inelastic demand," like if you tell [6:17] me that this drug will save my life costs $7 a month, I will pay you $7 a month for [6:23] it. If you tell me that it costs $124 a month, I will find a way to find $124 a month to [6:29] pay for it. You can't negotiate effectively on your own behalf for healthcare services [6:33] because you NEED them. And not like you need a Macbook Air or the new season of Sherlock, [6:38] but actual, physical need (I guess it is like the new season of Sherlock). [6:41] So basically, Hank, until and unless we can negotiate as effectively with the people providing [6:45] healthcare as Australians and British people do, US healthcare costs will continue to rise [6:50] faster than anywhere else in the world and we WON'T get better healthcare outcomes. [6:54] Hank, I know this video is long, although it could have been much longer, but I am so [6:58] tired of people offering up simple explanations for what's wrong with our healthcare system. [7:02] They say "Oh, it's malpractice," or "it's doctors who must also be businesspeople" or [7:06] "it's insurance companies" or "it's insane rules for who can GET insurance." It's drug [7:10] companies, it's government bureaucracy, it's an inability to negotiate prices. Yes, yes, [7:15] yes, yes, and YES! It is all of those things and more! It is not a simple problem, there [7:20] will not be a simple solution, but it is probably the biggest single drag on the American economy [7:26] and it's vital that we grapple with it meaningfully instead of just treating healthcare costs [7:30] as political theatre. [7:31] So I hope I've at least introduced the complexity of the problem. I've put some thoroughly nonpartisan [7:35] links in the doobly-doo for further reading. Hank, welcome back to the United States. As [7:39] you can see, everything is peachy here. I'll see you on Friday. [7:43] Friendly reminder, educational videos are allowed to be more than four minutes long. All of the people who are commenting about how [7:47] punished I am did not watch to the end of the video. I feel dizzy.